OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
MLL2/KMT2D and MLL3/KMT2C expression correlates with disease progression and response to imatinib mesylate in chronic myeloid leukemia
Doralina do Amaral Rabello Ramos, Vivían D’Afonseca, Maria Gabriela Berzoti-Coelho, et al.
Cancer Cell International (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 24
Doralina do Amaral Rabello Ramos, Vivían D’Afonseca, Maria Gabriela Berzoti-Coelho, et al.
Cancer Cell International (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 24
Showing 24 citing articles:
The lysine‐specific methyltransferase KMT 2C/ MLL 3 regulates DNA repair components in cancer
Θεόδωρος Ράμπιας, Dimitris Karagiannis, Margaritis Avgeris, et al.
EMBO Reports (2019) Vol. 20, Iss. 3
Open Access | Times Cited: 114
Θεόδωρος Ράμπιας, Dimitris Karagiannis, Margaritis Avgeris, et al.
EMBO Reports (2019) Vol. 20, Iss. 3
Open Access | Times Cited: 114
Immunogenomic Landscape Contributes to Hyperprogressive Disease after Anti-PD-1 Immunotherapy for Cancer
Donghai Xiong, Yian Wang, Arun K. Singavi, et al.
iScience (2018) Vol. 9, pp. 258-277
Open Access | Times Cited: 91
Donghai Xiong, Yian Wang, Arun K. Singavi, et al.
iScience (2018) Vol. 9, pp. 258-277
Open Access | Times Cited: 91
Targeting epigenetic machinery: Emerging novel allosteric inhibitors
Fei Ye, Jing Huang, Hongbo Wang, et al.
Pharmacology & Therapeutics (2019) Vol. 204, pp. 107406-107406
Open Access | Times Cited: 37
Fei Ye, Jing Huang, Hongbo Wang, et al.
Pharmacology & Therapeutics (2019) Vol. 204, pp. 107406-107406
Open Access | Times Cited: 37
Histone H3K4 Methyltransferases as Targets for Drug-Resistant Cancers
Yang Liu, Mingli Jin, Kwang Won Jeong
Biology (2021) Vol. 10, Iss. 7, pp. 581-581
Open Access | Times Cited: 28
Yang Liu, Mingli Jin, Kwang Won Jeong
Biology (2021) Vol. 10, Iss. 7, pp. 581-581
Open Access | Times Cited: 28
Predictive modeling of gene mutations for the survival outcomes of epithelial ovarian cancer patients
C. Mirielle, Ethan S. Lavi, Gary Altwerger, et al.
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0305273-e0305273
Open Access | Times Cited: 3
C. Mirielle, Ethan S. Lavi, Gary Altwerger, et al.
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0305273-e0305273
Open Access | Times Cited: 3
Pharmacoepigenetic Processors: Epigenetic Drugs, Drug Resistance, Toxicoepigenetics, and Nutriepigenetics
Ramón Cacabelos, Juan C. Carril, Ana Sanmartín, et al.
Elsevier eBooks (2019), pp. 191-424
Closed Access | Times Cited: 28
Ramón Cacabelos, Juan C. Carril, Ana Sanmartín, et al.
Elsevier eBooks (2019), pp. 191-424
Closed Access | Times Cited: 28
Cytotoxic and pro-apoptotic action of MjTX-I, a phospholipase A2 isolated from Bothrops moojeni snake venom, towards leukemic cells
Rogério Bodini Benati, Tássia Rafaela Costa, Maira da Costa Cacemiro, et al.
The Journal of venomous animals and toxins including tropical diseases (2018) Vol. 24, Iss. 1
Open Access | Times Cited: 25
Rogério Bodini Benati, Tássia Rafaela Costa, Maira da Costa Cacemiro, et al.
The Journal of venomous animals and toxins including tropical diseases (2018) Vol. 24, Iss. 1
Open Access | Times Cited: 25
Efficient mutation screening for cervical cancers from circulating tumor DNA in blood
Sun‐Young Lee, Dong‐Kyu Chae, Sung-Hun Lee, et al.
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 23
Sun‐Young Lee, Dong‐Kyu Chae, Sung-Hun Lee, et al.
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 23
Whole Exome Sequencing of Ulcerative Colitis–associated Colorectal Cancer Based on Novel Somatic Mutations Identified in Chinese Patients
Pengguang Yan, Yanan Wang, Xiangchen Meng, et al.
Inflammatory Bowel Diseases (2019) Vol. 25, Iss. 8, pp. 1293-1301
Open Access | Times Cited: 20
Pengguang Yan, Yanan Wang, Xiangchen Meng, et al.
Inflammatory Bowel Diseases (2019) Vol. 25, Iss. 8, pp. 1293-1301
Open Access | Times Cited: 20
Alginate/Carboxymethyl Chitosan Core-Shell Microspheres Coloaded with Doxorubicin/Docetaxel Reverse Chemotherapy Resistance in Anaplastic Thyroid Carcinoma
Yili Zhou, Fan Yang, Hongzhong Zhou, et al.
Thyroid (2024) Vol. 34, Iss. 7, pp. 856-870
Closed Access | Times Cited: 2
Yili Zhou, Fan Yang, Hongzhong Zhou, et al.
Thyroid (2024) Vol. 34, Iss. 7, pp. 856-870
Closed Access | Times Cited: 2
From Anti-EBV Immune Responses to the EBV Diseasome via Cross-reactivity
Darja Kanduc, Yehuda Shoenfeld
Global Medical Genetics (2020) Vol. 07, Iss. 02, pp. 051-063
Open Access | Times Cited: 16
Darja Kanduc, Yehuda Shoenfeld
Global Medical Genetics (2020) Vol. 07, Iss. 02, pp. 051-063
Open Access | Times Cited: 16
Identification of novel miRNAs potentially involved in the pathogenesis of adult T-cell leukemia/lymphoma using WGCNA followed by RT-qPCR test of hub genes
Ali Shayeghpour, Mohammad-Moien Forghani-Ramandi, Setayesh Solouki, et al.
Infectious Agents and Cancer (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 5
Ali Shayeghpour, Mohammad-Moien Forghani-Ramandi, Setayesh Solouki, et al.
Infectious Agents and Cancer (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 5
Bivalent chromatin as a therapeutic target in cancer: An in silico predictive approach for combining epigenetic drugs
Tomás Alarcón, Josep Sardanyés, Antoni Guillamon, et al.
PLoS Computational Biology (2021) Vol. 17, Iss. 6, pp. e1008408-e1008408
Open Access | Times Cited: 10
Tomás Alarcón, Josep Sardanyés, Antoni Guillamon, et al.
PLoS Computational Biology (2021) Vol. 17, Iss. 6, pp. e1008408-e1008408
Open Access | Times Cited: 10
A Computational Approach to Predict the Role of Genetic Alterations in Methyltransferase Histones Genes With Implications in Liver Cancer
Tania Isabella Aravena, Elizabeth Valdés, Nicolás Ayala, et al.
Cancer Informatics (2023) Vol. 22, pp. 117693512311614-117693512311614
Open Access | Times Cited: 3
Tania Isabella Aravena, Elizabeth Valdés, Nicolás Ayala, et al.
Cancer Informatics (2023) Vol. 22, pp. 117693512311614-117693512311614
Open Access | Times Cited: 3
Histone methyltransferase KMT2C plays an oncogenic role in prostate cancer
Zhenfei Li, Chengdang Xu, Xi Chen, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 148, Iss. 7, pp. 1627-1640
Closed Access | Times Cited: 5
Zhenfei Li, Chengdang Xu, Xi Chen, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 148, Iss. 7, pp. 1627-1640
Closed Access | Times Cited: 5
Epigenetic Control of Infant B Cell Precursor Acute Lymphoblastic Leukemia
Oriol de Barrios, Maribel Parra
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 3127-3127
Open Access | Times Cited: 7
Oriol de Barrios, Maribel Parra
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 3127-3127
Open Access | Times Cited: 7
Transformation of advanced lung adenocarcinoma to acquired T790M resistance mutation adenosquamous carcinoma following tyrosine kinase inhibitor: a case report
Qinghan Liu, Lin Wu, Suning Zhang
Tumori Journal (2020) Vol. 107, Iss. 6, pp. NP5-NP10
Closed Access | Times Cited: 6
Qinghan Liu, Lin Wu, Suning Zhang
Tumori Journal (2020) Vol. 107, Iss. 6, pp. NP5-NP10
Closed Access | Times Cited: 6
Research on epigenetic mechanism of SFRP2 in advanced chronic myeloid leukemia
Ziye Li, Jianmin Luo
Biochemical and Biophysical Research Communications (2018) Vol. 501, Iss. 1, pp. 64-72
Closed Access | Times Cited: 5
Ziye Li, Jianmin Luo
Biochemical and Biophysical Research Communications (2018) Vol. 501, Iss. 1, pp. 64-72
Closed Access | Times Cited: 5
The modification role and tumor association with a methyltransferase: KMT2C
Yunjuan Jiao, Yuanhao Lv, Mingjie Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Yunjuan Jiao, Yuanhao Lv, Mingjie Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Expression Analysis and Mutational Status of Histone Methyltransferase KMT2D at Different Upper Tract Urothelial Carcinoma Locations
Ekaterina Laukhtina, Ursula Lemberger, Andreas Bruchbacher, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 11, pp. 1147-1147
Open Access | Times Cited: 3
Ekaterina Laukhtina, Ursula Lemberger, Andreas Bruchbacher, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 11, pp. 1147-1147
Open Access | Times Cited: 3
<p>MLL3 promotes the senescence of esophageal squamous cell carcinoma</p>
Manhui Xia, Ling Feng, Feng Gao, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 1575-1582
Open Access | Times Cited: 2
Manhui Xia, Ling Feng, Feng Gao, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 1575-1582
Open Access | Times Cited: 2
WITHDRAWN: Involvement of KMT2 (MLL) family of methyltransferases in head and neck squamous cell carcinoma: A systematic review
Marcos Santos, Anna Karolina de Carvalho Abreu, Fábio Willian Martins da Silva, et al.
Oral Oncology Reports (2023), pp. 100058-100058
Open Access
Marcos Santos, Anna Karolina de Carvalho Abreu, Fábio Willian Martins da Silva, et al.
Oral Oncology Reports (2023), pp. 100058-100058
Open Access
Marcos Santos, Anna Karolina de Carvalho Abreu, Fábio Willian Martins da Silva, et al.
Head & Neck (2023) Vol. 46, Iss. 2, pp. 417-434
Open Access
Novel gene fusions found in cervical cancer
Yiwei Ling, Shujiro Okuda
EBioMedicine (2018) Vol. 38, pp. 13-14
Open Access
Yiwei Ling, Shujiro Okuda
EBioMedicine (2018) Vol. 38, pp. 13-14
Open Access
